Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Piperacillin/tazobactam vs ceftazidime + amikacin in pediatric oncology febrile neutropenia
TCTR20180205002Recruiting
- Sponsor
- Department of pediatrics, Faculty of medicine, Chiang Mai University
- Start
- Jun 2017
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial in febrile neutropenia (FN) and Infection comparing Piperacillin/tazobactam monotherapy with Ceftazidime plus amikacin (2 arms). Started Jun 2017; status: recruiting.
02
Drugs
piperacillin + tazobactamceftazidimeamikacin
03
Conditions
febrile neutropenia (FN)Infection
Beyond the preview
Go deeper on TCTR20180205002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180205002.